Table 2

Patient treatment

GroupTreatmentN
Group 1Single30
β-blockers15
Preserved timolol 0.5%8
PF-timolol 0.5%7
PGAs13
Latanoprost 0.005%8
PF-tafluprost 0.0015%7
Group 2Double23
Latanoprost-timolol fixed combination7
Bimatoprost and timolol unfixed combination7
Brimonidine and timolol unfixed combination4
Dorzolamide-timolol fixed combination5
Group 3Triple or more27
Bimatoprost 0.03%, brimonidine and timolol 0.05%14
Latanoprost 0.005%, timolol and dorzolamide7
Bimatoprost 0.03%, brimonidine, timolol 0.05% and dorzolamide6

  • PF, preservative free; PGAs, prostaglandin analogues.